Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Ann Otol Rhinol Laryngol. 2019 Dec 1;129(5):421–427. doi: 10.1177/0003489419892997

Table 2.

Eventual medication regimen at the six-month follow-up visit.

Medication No. of patients Proportion of the cohort
using medication
Nortriptyline 7 28%
Verapamil 6 24%
Topiramate 2 8%
Nortriptyline + Verapamil 5 20%
Nortriptyline + Topiramate 4 16%
Nortriptyline + Verapamil + Topiramate 1 4%